Reid M. Huber - Jun 8, 2022 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Douglas Barry, as attorney-in-fact
Stock symbol
TNGX
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
4
Date filed
6/28/2022, 04:27 PM
Previous filing
Jan 6, 2022
Next filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNGX Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jun 8, 2022 Common Stock 40K $5.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date.